Document:

Exhibit 10.22

 

EXECUTION
VERSION

 

WAIVER
AND LOCKUP AGREEMENT

 

This
Waiver and Lockup Agreement (this “Agreement”) is entered into as of December 23, 2020, by and between InterPrivate
Acquisition Corp, a Delaware corporation (the “IPV”), and [         ]
(“Sylebra”).

 

Recitals

 

WHEREAS,
IPV has entered into a Business Combination Agreement, dated as of November 2, 2020 (as amended, restated, or otherwise modified
from time to time, the “BCA”) for a business combination (the “Business Combination”) with
Aeva, Inc., a Delaware corporation (the “Target”), and IPV has filed a preliminary proxy statement with the
Securities and Exchange Commission pursuant to which IPV will solicit, among other things, stockholder approval of the Business
Combination (the “Stockholder Vote”);

 

WHEREAS,
on November 2, 2020, in connection with the business combination contemplated by the BCA, IPV entered into subscription agreements
with institutional accredited investors for the sale of an aggregate of 12,000,000 shares of common stock of IPV in a private
placement at a price of $10.00 per share for aggregate gross proceeds of $120,000,000, contingent on the consummation of the Business
Combination (the “Private Placement”);

 

WHEREAS,
IPV is conducting an additional private placement to enable Sylebra an opportunity to invest in IPV (the “Additional
Private Placement”);

 

WHEREAS,
Sylebra has executed a subscription agreement to purchase [          ] shares of
IPV common stock (the “Additional Private Placement Shares”) for an aggregate purchase price of $[         
] in the Additional Private Placement; 

 

WHEREAS,
in connection with the Stockholder Vote, public holders of IPV common stock may convert their shares into cash equal to their
pro rata share of the aggregate amount on deposit in IPV’s trust account, after deduction for certain amounts, including
taxes, as provided in IPV’s certificate of incorporation, as amended, and Sylebra desires to waive any such rights to convert
any shares of IPV common stock that it or its affiliates may now own or acquire prior to the Stockholder Vote (if any, the “Public
Shares”).

 

NOW,
THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement,
and for other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties
hereto agree as follows:

 

Agreement

 

1. Vote
of Public Shares. Sylebra agrees to vote, and shall cause its affiliates to vote, all Public Shares held of record or beneficially
by Sylebra or its affiliates on the record date to be set for the Stockholder Vote in favor of all the proposals upon which the
stockholders of IPV are entitled to vote in connection with the Stockholder Vote.

 

2. Non-Conversion
of Public Shares. Sylebra shall not, and shall cause its affiliates to not, submit any Public Shares for conversion in connection
with the Stockholder Vote.

 

     

     

    

 

3. Lock-Up
Agreement. Sylebra agrees to hold, and to not offer, sell, contract to sell, pledge, transfer, assign, or otherwise dispose
of, directly or indirectly, or hedge (including entering into any transactions involving any derivative securities of IPV and
including any Short Sales involving any of IPV’s securities) any of the Additional Private Placement Shares until the one
year anniversary following the consummation of the BCA (the “Lock-Up Period”). For purposes hereof, “Short
Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation
SHO under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), whether or not against the
box, and all types of direct and indirect stock pledges, forward sales contracts, options, puts, calls, short sales, swaps, “put
equivalent positions” (as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements (including on a total
return basis), and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers. During the Lock-Up
Period, Sylebra agrees to the imposition of a restrictive legend on each certificate or book-entry position representing the Additional
Private Placement Shares (in addition to the restrictive legend on the Additional Private Placement Shares specified in the subscription
agreement for such shares), as follows:

 

THE
SHARES REPRESENTED HEREBY ARE SUBJECT TO A LOCK-UP AGREEMENT BETWEEN THE ISSUER HEREOF AND THE HOLDER HEREOF, DATED DECEMBER 23,
2020, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE WITH SUCH AGREEMENT.

 

Notwithstanding
the foregoing, Sylebra may transfer or dispose of its shares following the closing of the Business Combination: (a) as a bona
fide gift or gifts, including to charitable organizations, (b) as a distribution to limited partners, members or shareholders
of Sylebra, (c) to its affiliated investment fund or other affiliated entity controlled or managed by Sylebra or its affiliates,
(d) to a nominee or custodian of a person to whom a disposition or transfer would be permissible under subclauses (a) through
(c) above, (e) pursuant to an order or decree of a governmental entity, (f) pursuant to a bona fide tender offer, merger, consolidation
or other similar transaction in each case made to all holders of the shares involving a Change of Control (as defined below) (including
negotiating and entering into an agreement providing for any such transaction), provided that in the event that such tender offer,
merger, consolidation or other such transaction is not completed, Sylebra’s shares shall remain subject to the provisions
of this section, (g) to IPV (1) pursuant to the exercise, in each case on a “cashless” or “net exercise”
basis, of any option to purchase shares granted by IPV, where any shares received by the undersigned upon any such exercise will
be subject to the terms of this section, or (2) for the purpose of satisfying any withholding taxes (including estimated taxes)
due as a result of the exercise of any option to purchase shares, on a “cashless” or “net exercise” basis,
where any shares received by Sylebra upon any such exercise will be subject to the terms of this Section, or (h) with the prior
written consent of the Company; provided that:

 

(1) in
the case of each transfer or distribution pursuant to subclauses (a) through (d) above, (a) each donee, trustee, distributee or
transferee, as the case may be, agrees to be bound in writing by the restrictions set forth in this section; and (b) any such
transfer or distribution shall not involve a disposition for value, other than with respect to any such transfer or distribution
for which the transferor or distributor receives (x) equity interests of such transferee or (y) such transferee’s interests
in the transferor;

 

(2) in
the case of each transfer or distribution pursuant to subclauses (a) through (d) above, if any public reports or filings (including
filings under Section 16(a) of the Exchange Act) reporting a reduction in beneficial ownership of shares shall be required or
shall be voluntarily made during the Lock-Up Period (x) Sylebra shall provide IPV prior written notice informing them of such
report or filing and (y) such report or filing shall disclose that such donee, trustee, distributee or transferee, as the case
may be, agrees to be bound in writing by the restrictions set forth herein; and

 

(3) for
purposes of subclause (x) above, “Change of Control” shall mean the transfer to or acquisition by (whether by tender
offer, merger, consolidation, division or other similar transaction), in one transaction or a series of related transactions,
a person or group of affiliated persons (other than an underwriter pursuant to an offering), of IPV’s voting securities
if, after such transfer or acquisition, such person or group of affiliated persons would beneficially own more than 50% of the
outstanding voting securities of the Company (or the surviving entity).

 

     

     

    

  

4. Representations
and Warranties of Sylebra. Sylebra represents and warrants to IPV, as of the date hereof:

 

a. Organization
and Power. Sylebra is duly organized, validly existing, and in good standing under the laws of the jurisdiction of its formation
and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

b. Authorization.
Sylebra has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by Sylebra will
constitute the valid and legally binding obligation of Sylebra enforceable against it in accordance with its terms, except (i)
as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general
application affecting enforcement of creditors’ rights generally, or (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies.

 

c. Compliance
with Other Instruments. The execution, delivery and performance by Sylebra of this Agreement and the consummation by Sylebra
of the transactions contemplated by this Agreement will not result in any violation or default (i) of any provisions of its organizational
documents, (ii) of any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under
any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase
order to which it is a party or by which it is bound or (v) of any provision of any statute, rule or regulation of any jurisdiction
applicable to Sylebra, in each case (other than clause (i)), which would have a material adverse effect on Sylebra or its ability
to satisfy its obligations under this Agreement.

 

d. No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this
Agreement and in any certificate or agreement delivered pursuant hereto (including, without limitation, a subscription agreement
for the purchase of the Additional Private Placement Shares), neither Sylebra nor any person acting on behalf of Sylebra nor any
of Sylebra’s affiliates (the “Sylebra Parties”) has made, makes or shall be deemed to make any other
express or implied representation or warranty with respect to Sylebra, and the Sylebra Parties disclaim any such representation
or warranty.

 

5. Representations
and Warranties of IPV. IPV represents and warrants to Sylebra as follows:

 

a. Organization
and Corporate Power. IPV is a corporation duly incorporated and validly existing and in good standing as a corporation under
the laws of the State of Delaware and has all requisite corporate power and authority to carry on its business as presently conducted
and as proposed to be conducted.

 

b. Authorization.
All corporate action required to be taken by IPV’s Board of Directors in order to authorize IPV to enter into this Agreement
has been taken. All action on the part of the directors and officers of IPV necessary for the execution and delivery of this Agreement
and the performance of all obligations of IPV under this Agreement to be performed hereunder, has been taken or will be taken
prior to the consummation of the Private Placement. This Agreement, when executed and delivered by the parties hereto, shall constitute
the valid and legally binding obligation of IPV, enforceable against IPV in accordance with its terms except (i) as limited by
applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating
to or affecting the enforcement of creditors’ rights generally, or (ii) as limited by laws relating to the availability
of specific performance, injunctive relief, or other equitable remedies.

 

    2

     

    

 

c. Compliance
with Other Instruments. The execution, delivery and performance of this Agreement and the consummation of the transactions
contemplated by this Agreement will not result in any violation or default (i) of any provisions of the certificate of incorporation,
bylaws or other governing documents of IPV, (ii) of any instrument, judgment, order, writ or decree to which IPV is a party or
by which it is bound, (iii) under any note, indenture or mortgage to which IPV is a party or by which it is bound, (iv) under
any lease, agreement, contract or purchase order to which IPV is a party or by which it is bound or (v) of any provision of federal
or state statute, rule or regulation applicable to IPV, in each case (other than clause (i)) which would have a material adverse
effect on IPV or its ability to consummate the transactions contemplated by this Agreement.

 

d. No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this
Agreement and in any certificate or agreement delivered pursuant hereto (including, without limitation, a subscription agreement
for the purchase of the Additional Private Placement Shares), none of (i) IPV, (ii) any person on behalf of IPV, nor (iii) any
of IPV’s affiliates (clauses (i) through (iii), collectively, the “IPV Parties”) has made, makes or shall
be deemed to make any other express or implied representation or warranty with respect to IPV, or the Business Combination, and
the IPV Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly
made by Sylebra in this Agreement and in any certificate or agreement delivered pursuant hereto (including, without limitation,
a subscription agreement for the purchase of the Additional Private Placement Shares), the IPV Parties specifically disclaim that
they are relying upon any other representations or warranties that may have been made by the Sylebra Parties.

 

6. Termination.
This Agreement may be terminated as follows:

 

a. at
any time by mutual written consent of IPV and Sylebra; and

 

b. automatically
if the BCA is terminated in accordance with its terms.

 

In
the event of termination in accordance with Section 6.a. or Section 6.b., this Agreement shall forthwith become
null and void and have no effect, without any liability on the part of Sylebra or IPV or their respective directors, officers,
employees, partners, managers, members, or stockholders and all rights and obligations of each party shall cease; provided,
however, that nothing contained in this Section 6 shall relieve any party from liabilities or damages arising out of
any fraud or willful breach by such party of any of its representations, warranties, covenants or agreements contained in this
Agreement.

 

7. General
Provisions.

 

a. Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given upon the earlier of actual receipt, or (i) personal delivery to the party to be notified, (ii) when sent, if sent by
electronic mail or facsimile (if any) during normal business hours of the recipient, and if not sent during normal business hours,
then on the recipient’s next business day, (iii) five business days after having been sent by registered or certified mail,
return receipt requested, postage prepaid, or (iv) one business day after deposit with an internationally recognized overnight
courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications sent
to IPV shall be sent to: c/o InterPrivate LLC, 1350 Avenue of the Americas, New York, New York 10019 or by email to
bbentley@interprivate.com, Attention: General Counsel. All communications to Sylebra shall be sent to the address as set forth
on the signature page hereof. Any party may modify its e-mail address, facsimile number (if any) or address by written notice
given to the other parties in accordance with this Section 7.a.

 

b. Survival
of Representations and Warranties. All of the representations and warranties contained herein shall survive the closing of
the purchase of the Additional Private Placement Shares.

 

c. Entire
Agreement. This Agreement, together with any documents, instruments and writings that are delivered pursuant hereto or referenced
herein (including the subscription agreement for the purchase of the Additional Private Placement Shares), constitute the entire
agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements,
or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter
hereof or the transactions contemplated hereby.

 

    3

     

    

 

 

d. Successors.
All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure
to the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express
or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any
rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

e. Assignments.
Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its rights, interests,
or obligations hereunder without the prior written approval of the other party.

 

f. Counterparts.
This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which together
will constitute one and the same instrument.

 

g. Headings.
The section headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning
or interpretation of this Agreement.

 

h. Governing
Law. This Agreement, the entire relationship of the parties hereto, and any litigation between the parties (whether grounded
in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the
laws of the State of Delaware, without giving effect to its choice of laws principles.

 

i. Jurisdiction.
The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of New York located in New
York County and to the jurisdiction of the United States District Court for the Southern District of New York located in New York
County for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (ii) agree not to
commence any suit, action or other proceeding arising out of or based upon this Agreement except in state courts of New York located
in New York County or the United States District Court for the Southern District of New York, and (iii) hereby waive, and agree
not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not
subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution,
that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper
or that this Agreement or the subject matter hereof may not be enforced in or by such court.

 

j. Waiver
of Jury Trial. The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this
Agreement and the transactions contemplated hereby.

 

k. Amendments.
This Agreement may not be amended, modified or waived as to any particular provision, except with the prior written consent of
IPV and Sylebra.

 

l. Severability.
The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect
the validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied
to any party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable
in accordance with its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making such determination
will have the power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to
delete specific words or phrases, and in its reduced form, such provision will then be enforceable and will be enforced.

 

m. Expenses.
Each of IPV and Sylebra will bear its own costs and expenses incurred in connection with the preparation, execution and performance
of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives,
financial advisors, legal counsel and accountants.

 

    4

     

    

 

n. Construction.
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of
intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption
or burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement.
Any reference to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations
promulgated thereunder, unless the context requires otherwise. The words “include,” “includes,”
and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine,
feminine, and neuter genders will be construed to include any other gender, and words in the singular form will be construed to
include the plural and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,”
“hereof,” “hereby,” “hereunder,” and words of similar import refer to
this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each
representation, warranty, and covenant contained herein will have independent significance. If any party hereto has breached any
representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty
or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has
not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty,
or covenant. Any share amounts and prices shall be adjusted appropriately and in good faith by the parties to reflect the effect
of any stock split, reverse stock split, stock dividend (including any dividend or other distribution of securities convertible
into IPV common stock), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change
with respect to IPV common stock at any time prior to a determination pursuant to this Agreement, so as to provide the parties
with the same economic effect as contemplated by this Agreement prior to such event.

 

o. Waiver.
No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional
or not, may be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder
or affect in any way any rights arising because of any prior or subsequent occurrence.

 

p. Specific
Performance. Each party agrees that irreparable damage may occur in the event any provision of this Agreement was not performed
by the other party in accordance with the terms hereof and that the other party shall be entitled to seek specific performance
of the terms hereof, in addition to any other remedy at law or equity.

 

[signature
page follows]

 

    5

     

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

[         ]

 

	By:
    	        	 
	Name:
    	 	 
	Title:  	 	 
	 	 	 
	Address
    for Notices:  	 
	[      ]	 	 
	 	 	 
	INTERPRIVATE ACQUISITION CORP.	 
	 	 	 
	By:	                   	 
	Name:  	 	 
	Title:Exhibit 10.33

 

DEBT
CONVERSION AGREEMENT

 

This
Debt Conversion Agreement (the “Agreement”) is entered into effective as of May 2, 2019 by and between Liu
Shu Juan (“Investor”) and Moxian, Inc., a Nevada corporation(the “Company”), with reference
to the following facts:

 

WHEREAS,

 

(i)
Investor has loaned certain funds to the Company totaling $5,032,760, of which $4,000,000 is described in the Loan Agreement
dated May 11, 2018 (the “Loan Agreement”), and $1,032,760 is in the form of unsecured advances to the
Company.

 

(ii)
Investor has agreed to waive its right to a repayment of $4,272,760 of the amount owed by the Company and

 

(iii)
The Company and Investor now desire to convert the remaining balance of $750,000 (the “Debt”) into shares
of Common Stock .

 

NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Investor and the
Company agree as follows:

 

1.
Conversion to Common Stock. Effective as of May 2, 2019, $750,000 of the Debt shall be converted into shares of Common
Stock at a price per share of $1.50 for an aggregate number of shares of 500,000. Upon execution of this Agreement, the Company
shall instruct its transfer agent to issue a total of 500,000 shares of Common Stock to the Investor, and the Investor shall acknowledge
the repayment of the entire amount under the Loan Agreement.

 

2.
Investor Representations. The Company is issuing the Common Stock to Investor in reliance upon the following representations
made by Investor:

 

(a)
Investor acknowledges and agrees that the shares of Common Stock are characterized as “restricted securities” under
the Securities Act of 1933 (as amended and together with the rules and regulations promulgated thereunder, the “Securities
Act”) and that, under the Securities Act and applicable regulations thereunder, such securities may not be resold, pledged
or otherwise transferred without registration under the Securities Act or an exemption therefrom. Investor acknowledges and agrees
that (i) the shares of Common Stock are being offered in a transaction not involving any public offering in the United States
within the meaning of the Securities Act, and the shares of Common Stock have not yet been registered under the Securities Act,
and (ii) such shares of Common Stock may be offered, resold, pledged or otherwise transferred only in a transaction registered
under the Securities Act, or meeting the requirements of Rule 144, or in accordance with another exemption from the registration
requirements of the Securities Act (and based upon an opinion of counsel if the Company so requests) and in accordance with any
applicable securities laws of any State of the United States or any other applicable jurisdiction.

 

    	 

    	 

    

 

(b)
Investor acknowledges and agrees that (i) the registrar or transfer agent for the shares of Common Stock will not be required
to accept for registration of transfer any shares except upon presentation of evidence satisfactory to the Company that the restrictions
on transfer under the Securities Act have been complied with and (ii) any shares of Common Stock in the form of definitive physical
certificates will bear a restrictive legend.

 

(c)
Investor acknowledges and agrees that:

 

(a)
the shares of Common Stock have not been registered under the Securities Act, or under any state securities laws, and are being
offered and sold in reliance upon federal and state exemptions for transactions not involving any public offering;

 

(b)
Investor is acquiring the shares of Common Stock solely for its own account for investment purposes, and not with a view to the
distribution thereof in a transaction that would violate the Securities Act or the securities laws of any State of the United
States or any other applicable jurisdiction;

 

(c)
Investor is a sophisticated purchaser with such knowledge and experience in business and financial matters that it is capable
of evaluating the merits and risks of purchasing the shares of Common Stock;

 

(d)
Investor has had the opportunity to obtain from the Company such information as desired in order to evaluate the merits and the
risks inherent in holding the shares of Common Stock;

 

(e)
Investor is able to bear the economic risk and lack of liquidity inherent in holding the shares of Common Stock;

 

(f)
Investor is an “accredited investor” within the meaning of Rule 501(a) under the Securities Act; and

 

(g)
Investor either has a pre-existing personal or business relationship with the Company or its officers, directors or controlling
persons, or by reason of Investor’s business or financial experience, or the business or financial experience of their professional
advisors who are unaffiliated with and who are not compensated by the Company, directly or indirectly, have the capacity to protect
their own interests in connection with the purchase of the Common Stock.

 

(d)
Investor’s investment in the Company pursuant to this Common Stock is consistent, in both nature and amount, with Investor’s
overall investment program and financial condition.

 

(e)
Investor’s principal residence is in the Peoples’ Republic of China.

 

3.
Miscellaneous.

 

(a)
This Agreement shall be construed and enforced in accordance with the laws of the State of Nevada.

 

(b)
This Agreement constitutes the entire agreement between the parties and supersedes all prior oral or written negotiations and
agreements between the parties with respect to the subject matter hereof. No modification, variation or amendment of this Agreement
(including any exhibit hereto) shall be effective unless made in writing and signed by both parties.

 

(c)
Each party to this Agreement hereby represents and warrants to the other party that it has had an opportunity to seek the advice
of its own independent legal counsel with respect to the provisions of this Agreement and that its decision to execute this Agreement
is not based on any reliance upon the advice of any other party or its legal counsel. Each party represents and warrants to the
other party that in executing this Agreement such party has completely read this Agreement and that such party understands the
terms of this Agreement and its significance. This Agreement shall be construed neutrally, without regard to the party responsible
for its preparation.

 

    	 

    	 

    

 

(d)
Each party to this Agreement hereby represents and warrants to the other party that (i) the execution, performance and delivery
of this Agreement has been authorized by all necessary action by such party; (ii) the representative executing this Agreement
on behalf of such party has been granted all necessary power and authority to act on behalf of such party with respect to the
execution, performance and delivery of this Agreement; and (iii) the representative executing this Agreement on behalf of such
party is of legal age and capacity to enter into agreements which are fully binding and enforceable against such party.

 

(e)
This Agreement may be executed in any number of counterparts and may be delivered by facsimile transmission, all of which taken
together shall constitute a single instrument.

 

This
Agreement is entered into and effective as of the date first written above.

 

	COMPANY:  	 	INVESTOR:
	 	 	 
	Moxian, Inc.  	 	 
	 	 	 	 
	By:	 	 	 
	 	 	 	 
	 	Hao Qinghu, CEO	 	Liu Shu Juan

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]